Getty Images
August 2, 2022 — The American College of Radiology (ACR) Center for Research and Innovation (CRI) will serve as the operations center for the new Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET) announced August 1 at the Alzheimer’s Association International Conference (AAIC) 2022.
ACR Neuroradiology Research Committee Chair Christopher T. Whitlow, MD, PhD, MHA, is a co-investigator for ALZ-NET, which will collect long-term clinical and safety data from patients treated with FDA-approved Alzheimer’s disease (AD) therapies.
ACR CRI will also provide guidance, education and best practices in imaging care for dementia and AD patients. Imaging serves a pivotal role in AD diagnosis and routine safety monitoring of AD therapy patients.
Clinical dementia care sites will participate directly in ALZ-NET. Imaging facilities will provide optimal imaging care to patients and thorough reporting to treating clinicians.
ALZ-NET partner organizations include the Alzheimer's Association, the ACR, Critical Path Institute, Department of Biostatistics at Brown University School of Public Health and the American Society of Neuroradiology, along with other clinical research and imaging experts.
For more information: https://www.acr.org/Research/Clinical-Research/ALZNET
Related Alzheimer's Content:
FDA Grants Accelerated Approval for Alzheimer’s Drug Aduhelm
VIDEO: Researchers Use MRI to Predict Alzheimer's Disease
Brain Iron Accumulation Linked to Cognitive Decline in Alzheimer's Patients
Good Results for Alzheimer’s Imaging Agent
NIH Augments Large Scale Study of Alzheimer’s Disease Biomarkers
Alzheimer’s Association Launches New Website for IDEAS Study
PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment
July 28, 2026 
